May 22, 2009

What They're Buying

SuperInvestors stepped to the plate and swung hard at battered blue-chips like Microsoft and Pfizer, as well as at commodity-related cyclicals like Companhia Vale do Rio Doce, Williams and Transocean.

	Table:		Into the Zone

	Table:		Big Swings

What They're Selling

Companies most leveraged to the health of the economy, such as American Express and Wells Fargo, and those attempting turnarounds, like Sears and Wendy's, came in for active selling last quarter.

	Table:		Sources of Funds

	Table:		Selling Out

What They Own

The stocks most widely held at the end of the quarter didn't dramatically change, but the list of companies on which SuperInvestors are doubling down is full of surprises.

	Table:		Crowd Mentality

	Table:		Doubling Down

Stock Spotlight

Top investors seem to highly value Thermo Fisher Scientific's stable, high-quality business. The market, for the time being, has yet to concur.

Companies in this Issue

A – E

Abercrombie & Fitch, Allegheny Energy, American Express, American Tower, AmerisourceBergen, Anadarko Petroleum, Apartment Investment & Management, Apple, Aspen Insurance, Avon, BCE, Burlington Northern Santa Fe, CF Industries, CSX, CVS Caremark, CapitalSource, Comcast, Companhia Vale do Rio Doce, Dr Pepper Snapple, Eaton, EnCana, Exco Resources

F – J

Fidelity National Information, Fiserv, Fomento Economico, Google, JPMorgan Chase

K – O

Kimberly-Clark, Lorillard, MasterCard, Microsoft, Monsanto, NRG Energy, NYSE Euronext, Oracle

P – T

Pfizer, Philip Morris International, Potash Corp. of Saskatchewan, Precision Castparts, Qualcomm, R.R. Donnelley, SLM, SPDR Gold Trust, Sears, St. Jude Medical, Thermo Fisher Scientific, Transocean, Tyco Electronics, Tyco International

U – Z

U.S. Bancorp, Union Pacific, UnitedHealth, Visa, WellPoint, Wells Fargo, Wendy’s/Arby’s, Williams, Wyndham Worldwide, XTO Energy, Yum Brands